Search Results 3121-3130 of 26197 for oral
... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...
... (oral, injectable, or implantable), intrauterine device, intrauterine hormone ... Patients with active, known, or suspected auto-immune disease or a syndrome that ...
... oral calcineurin inhibitors; high potency or oral steroids). Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on ...
... orally to patients with advanced solid tumors, including RET-fusion-positive solid tumors, medullary thyroid cancer (MTC) and other tumors with RET activation.
An allergic reaction is a red, itchy bump where the allergen was put on the skin. The most common side effects of these skin tests are itching and redness.
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
Paulette had oral cancer. She was shocked. "I always took such good care of my mouth, so this was the furthest from my mind," Paulette says.
A levonorgestrel-releasing intrauterine device (IUD) or oral contraceptives, decreases menstrual bleeding and provides contraception. Hysteroscopic ...
... oral therapy) for 90 days prior to Baseline. Subject has pulmonary veno-occlusive disease. Malignancy diagnosed and/or treated within 5 years prior to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.